Frequently Asked Questions

  1. What do you charge for Comprehensive Pan-Cancer Next Generation Sequencing (DNA and RNA)?

    Patient care: $2,920.00 per case.

    Research Fee Schedule

  2. What are the average values of some recent coverage amounts?

    Insurance Coverage Summary Table (as of October 2019)

    NOTE: In our experience, we do not know if a test will be covered until insurance processes the claim.  The above amounts covered are also only an estimate based on our experiences to date and may thus differ from the amount covered for an individual patient.

  3. What are some ICD-10 codes providers have listed when insurances covers the test?

    Medicare/Medicare Managed Care:

    -C50.011 or C50.912 (breast cancer)

    -C91.92 (lymphoid leukemia) 

    Cigna:

    -C64.2 (renal cancer)

    -C77.1 (secondary lymph node cancer)

    -C83.00 (B-cell lymphoma)

    United Healthcare:

    -C67.9 (bladder cancer)

    -D46.9 (myelodysplastic syndrome)

    -D72.829 (elevated WBC)

    Blue Cross Blue Shield:

    -C91.90 (lymphoid leukemia)

    -C92.00 (myeloid leukemia)

    -D61.818 (pancytopenia)

    -D72.829 (elevated WBC)

  4. What can I do if my insurance denies coverage?

    Your provider can appeal with assistance from our medical director. If coverage is denied following an appeal, you will be responsible for $2,190.00 after a self-pay discount.

  5. Do you accept orders from non-UTSW providers?

    Yes. All the documents and instructions a provider needs to initiate the testing process can be found via the "Ordering a Test" link (available 1) on the home page, 2) under the "Services We Offer" tab or 3) on almost every page on the site under "Additional Links").

  6. How long it will take a get the final report?

    After we receive all documents and specimens, the final report will be uploaded into UTSW's electronic health record or sent to the ordering physician (non-UTSW patients) within 15 business days.

  7. What do you do if I cannot provide germline (non-tumor) tissue?

    We can do tumor-only sequencing, although it decreases the accuracy of the data. We strongly prefer to have a germline specimen accompany a tumor specimen.

  8. What do you do if you find a pathogenic mutation in germline (non-tumor) tissue?

    For UTSW patients, we will contact the genetics clinic on campus to help the patient access appropriate counseling.

    For non-UTSW patients, we will call the ordering provider to make her or him aware of the importance of genetic counseling. If a patient has a strong opposition to learning about out germline mutations, we can omit such results from the report at the ordering provider's request (phone call required).

Back to Top